Harpoon Therapeutics, Inc. Common Stock
HARP
HARP was delisted on the 8th of March, 2024.
84 hedge funds and large institutions have $196M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 23 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
1% more call options, than puts
Call options by funds: $463K | Put options by funds: $457K
0.42% more ownership
Funds ownership: 78.98% → 79.4% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less capital invested
Capital invested by funds: $204M → $196M (-$7.62M)
10% less funds holding
Funds holding: 93 → 84 (-9)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$13.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.44M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$2.18M |
| 4 |
O
OrbiMed
New York
|
+$1.99M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$9.41M |
| 2 |
Millennium Management
New York
|
-$3.42M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$2.42M |
| 4 |
Renaissance Technologies
New York
|
-$2.38M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.98M |
HARP Hedge Fund Activity: Q4 2021 in Review
84 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q4 2021, worth a combined $196M — down 3.7% from $204M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of HARP and 15 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 28 added.
The largest buyer was Logos Global Management, opening a new position worth an estimated $13.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $9.41M sold.
- 84 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q4 2021, down from 93 in Q3 2021.
- Funds reported $196M of Harpoon Therapeutics, Inc. Common Stock stock for Q4 2021, down 3.7% quarter-over-quarter.
- 15 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q4 2021 and 23 closed out, a net change of -8 holders.
- The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q4 2021 was Logos Global Management, an estimated $13.2M added.
- The largest Harpoon Therapeutics, Inc. Common Stock seller in Q4 2021 was Avidity Partners Management, an estimated $9.41M sold.
Based on aggregated 13F filings for Q4 2021.